Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (67)
2025 (849)
2024 (934)
2023 (918)
2022 (1034)
2021 (1042)
2020 (874)
2019 (789)
2018 (912)
2017 (936)
2016 (881)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (11760)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Liver Int.
JSON
ISSN
1478-3231
ISSN-L
1478-3223
IUID
fabb5472c1cc4b248eee80ab03c9277c
Modified
2020-11-27T13:12:54.529Z
Created
2018-12-05T09:11:56.481Z
Year 2023
PubMed
DOI
Crossref
Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study.
Ebrahimi F
,
Simon TG
,
Hagström H
, ...,
Engstrand L
,
Ludvigsson JF
Liver Int.
43
(10) 2186-2197 [2023-10-00; online 2023-06-30]
Year 2020
PubMed
DOI
Crossref
Cell-type-resolved proteomic analysis of the human liver.
Ölander M
, Wiśniewski JR,
Artursson P
Liver Int.
40
(7) 1770-1780 [2020-07-00; online 2020-04-12]
Year 2017
PubMed
DOI
Crossref
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
Mikus M, Drobin K, Gry M, ..., Nilsson P, Schuppe-Koistinen I
Liver Int.
37
(1) 132-140 [2017-01-00; online 2016-06-22]
Affiliated researcher
Year 2014
PubMed
DOI
Crossref
Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.
Thulin P, Nordahl G, Gry M, ..., Glinghammar B, Schuppe-Koistinen I
Liver Int.
34
(3) 367-378 [2014-03-00; online 2013-10-14]
SciLifeLab Data Centre
Publications
9.5.1